Comparing bowel and urinary domains of patient-reported quality of life at the end of and 3 months post radiotherapy between intensity-modulated radiotherapy and proton beam therapy for clinically localized prostate cancer.

Cancer Med · 2020 · PMC7643652 · PMID 32931662

Europe PMC DOI

hedged sentence

0.0200

closest p · 0.4× alpha

0.0200

boldest claim

The sentences

borderline significanceP = .02actually significant

This difference was statistically significant at the end of RT ( P = .01) and had borderline significance ( P = .02) at 3 months post‐RT. 3.3.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.